ACA
Avoro Capital Advisors Portfolio holdings
AUM
$10.2B
1-Year Est. Return
119.73%
This Fund
S&P 500
1 Year Est. Return
+119.73%
AUM
$7.73B
AUM Growth
+$2.02B
(+35%)
Holding
33
Top Buys
| 1 | +$103M | |
| 2 | +$103M | |
| 3 | +$39.1M | |
| 4 |
Ocular Therapeutix
OCUL
|
+$34.1M |
| 5 |
MRUS
Merus
MRUS
|
+$25.2M |
Top Sells
| 1 | +$122M | |
| 2 | +$117M | |
| 3 | +$112M | |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
+$48.1M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$27.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$14.1B
| $1.02B | 13.14% |
5,110,000
+130,000
|
|
||
2
United Therapeutics
UTHR
$20.7B
| $848M | 10.97% |
2,022,222
-347,778
|
|
||
3
Madrigal Pharmaceuticals
MDGL
$9.92B
| $841M | 10.88% |
1,833,000
-42,000
|
|
||
4
argenx
ARGX
$52.4B
| $730M | 9.45% |
990,000
-185,000
|
|
||
5
Krystal Biotech
KRYS
$7.62B
| $490M | 6.34% |
2,777,777
+117,777
|
|
||
6
Arrowhead Research
ARWR
$8.94B
| $376M | 4.86% |
10,900,000
+300,000
|
|
||
7
Kymera Therapeutics
KYMR
$6.92B
| $359M | 4.65% |
6,350,000
-205,555
|
|
||
|
MRUS
8
DELISTED
Merus
MRUS
| $334M | 4.31% |
3,542,500
+386,945
|
|
||
9
Avidity Biosciences
RNA
$11.3B
| $333M | 4.31% |
7,645,000
+595,000
|
|
||
10
Apellis Pharmaceuticals
APLS
$2.88B
| $277M | 3.58% |
12,222,222
|
|
||
|
CNTA
11
Centessa Pharmaceuticals
CNTA
$3.69B
| $262M | 3.39% |
10,808,080
+5,808,080
|
|
||
12
uniQure
QURE
$1.52B
| $259M | 3.36% |
4,444,444
+819,444
|
|
||
13
Xenon Pharmaceuticals
XENE
$3.33B
| $217M | 2.8% |
5,400,000
|
|
||
|
AKRO
14
DELISTED
Akero Therapeutics
AKRO
| $188M | 2.43% |
3,955,555
+455,555
|
|
||
15
Vera Therapeutics
VERA
$2.99B
| $180M | 2.33% |
6,210,000
-90,000
|
|
||
16
Soleno Therapeutics
SLNO
$2.12B
| $174M | 2.25% |
2,577,777
+527,777
|
|
||
17
Structure Therapeutics
GPCR
$4.77B
| $144M | 1.87% |
+5,155,555
|
|
||
|
TRML
18
DELISTED
Tourmaline Bio
TRML
| $122M | 1.58% |
2,555,555
|
|
||
|
19
Ocular Therapeutix
OCUL
$1.53B
| $120M | 1.55% |
10,250,000
+2,850,000
|
|
||
20
Amicus Therapeutics
FOLD
$4.5B
| $118M | 1.53% |
15,025,000
-2,975,000
|
|
||
|
ETNB
21
DELISTED
89bio
ETNB
| $93.9M | 1.21% |
6,387,790
-362,210
|
|
||
22
Taysha Gene Therapies
TSHA
$1.31B
| $71M | 0.92% |
21,700,000
|
|
||
23
Alkermes
ALKS
$5.28B
| $67.2M | 0.87% |
2,240,000
-660,000
|
|
||
|
ORKA
24
Oruka Therapeutics
ORKA
$1.57B
| $25.6M | 0.33% |
+1,333,340
|
|
||
|
SEPN
25
Septerna Inc
SEPN
$1.21B
| $25.2M | 0.33% |
1,337,500
+100,000
|
|